Welcome to our dedicated page for DXC Technology Co SEC filings (Ticker: DXC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on DXC Technology Co's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into DXC Technology Co's regulatory disclosures and financial reporting.
DXC Technology Co (DXC) reported that its President, Paul James Taylor, received two equity compensation awards of common stock on September 15, 2026. He was granted 204,280 restricted stock units as a prorated FY27 award and 145,914 restricted stock units as a one-time inducement award. Each RSU converts into one share of common stock upon vesting, and both awards vest in three equal annual installments beginning September 15, 2027.
DXC Technology Co (symbol: DXC) is the issuer of record for a Form 4 filing submitted to the SEC.
DXC Technology Co (DXC) reported an insider tax-withholding transaction by executive Venkataraman Ramanathan, EVP, CES. On August 14, 2026, 14,247 shares of common stock were withheld at $10.79 per share to satisfy tax liabilities arising from the vesting of 28,927 restricted stock units (RSUs). Following this withholding, Ramanathan’s directly held position is 230,688 shares, which the company states includes unvested RSUs.
DXC Technology Co reported that Paul James Taylor is an officer of the company, serving as President, DXC
DXC Technology Co received an amended Schedule 13G from Glenview Capital Management, LLC and Larry Robbins reporting that, as of June 30, 2026, they may be deemed the beneficial owners of 0 shares of DXC common stock. The filing states they hold 0% of the class, with no sole or shared power to vote or dispose of any shares. The shares previously related to accounts of Glenview Capital Master Fund, Ltd. and Glenview Offshore Opportunity Master Fund, Ltd., for which Glenview Capital Management serves as investment manager and Mr. Robbins is Chief Investment Officer. The amendment confirms their current ownership is below 5% of DXC’s outstanding common stock.
American Century entities report a significant ownership position in DXC Technology Company common stock. As of June 30, 2026, American Century ETF Trust reports beneficial ownership of 10,022,365 shares, representing 6.2% of the outstanding common stock. American Century Investment Management, Inc., American Century Companies, Inc., and Stowers Institute for Medical Research each report beneficial ownership of 10,436,267 shares, representing 6.4% of the class, with sole voting and dispositive power over these shares. Various investment company clients and institutional accounts advised by American Century Investment Management have rights to dividends and sale proceeds, but no single client holds more than 5% of the class.
DXC Technology Company received an amended Schedule 13G filing indicating that Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander collectively report beneficial ownership of 6,613,586 shares of DXC common stock. This represents 4.1% of the outstanding common stock.
The reporting persons have shared voting power over 6,607,521 shares and shared dispositive power over 6,613,586 shares, with no sole voting or dispositive power reported. The shares are held by entities over which Millennium Management LLC and related investment managers exercise voting control and investment discretion, and the filers state that this should not by itself be construed as an admission of beneficial ownership. The filing also notes that the group now holds ownership of 5 percent or less of the class.
Herzog David L reported acquisition or exercise transactions in this Form 4 filing.
DXC Technology Co director David L. Herzog received a grant of 30,900 restricted stock units (RSUs) representing common stock on August 4, 2026. Each RSU entitles him to one share of common stock and will vest on the earlier of one year from the grant date or the 2027 annual meeting of stockholders, with settlement at vesting or a deferred date if elected.
After this award, Herzog directly holds 147,301 shares of DXC common stock, and this amount includes unvested RSUs.
Washington Akihiko reported acquisition or exercise transactions in this Form 4 filing.
DXC Technology Co reported that director Akihiko Washington received an award of 21,800 restricted stock units of common stock on 2026-08-04. Each RSU represents one DXC share and will vest on the earlier of one year from the grant date or the 2027 annual meeting of stockholders. Following this award, Washington directly holds 79,300 shares, a figure that includes unvested RSUs. The RSUs settle on the vesting date or on a later date if he has elected to defer settlement.
Gonzalez Anthony reported acquisition or exercise transactions in this Form 4 filing.
DXC Technology director Anthony Gonzalez received an award of 21,800 restricted stock units, each entitling him to one share of common stock. The RSUs vest on the earlier of one year from the 2026-08-04 grant date or the 2027 annual meeting, increasing his direct holdings to 56,100 shares, including unvested RSUs.